Citadel Advisors’s iHuman IH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$42.7K Buy
25,028
+4,314
+21% +$8K ﹤0.01% 12461
2025
Q4
$43.5K Buy
20,714
+4,556
+28% +$12.1K ﹤0.01% 12097
2025
Q3
$46.7K Sell
16,158
-19,229
-54% -$53.3K ﹤0.01% 12241
2025
Q2
$88.5K Sell
35,387
-20,107
-36% -$44.8K ﹤0.01% 11422
2025
Q1
$118K Buy
55,494
+7,811
+16% +$15.6K ﹤0.01% 11236
2024
Q4
$80.6K Buy
47,683
+9,314
+24% +$16.6K ﹤0.01% 11773
2024
Q3
$88.2K Sell
38,369
-1,349
-3% -$2.21K ﹤0.01% 11283
2024
Q2
$71.1K Buy
39,718
+20,745
+109% +$38.4K ﹤0.01% 11359
2024
Q1
$32.3K Buy
+18,973
New +$44K ﹤0.01% 12627
2023
Q4
Sell
-14,510
Closed -$43.8K 14744
2023
Q3
$43.8K Buy
14,510
+4,146
+40% +$12.8K ﹤0.01% 11902
2023
Q2
$30.7K Buy
+10,364
New +$32.1K ﹤0.01% 12332
2021
Q3
Sell
-49,923
Closed -$516K 14198
2021
Q2
$516K Buy
+49,923
New +$550K ﹤0.01% 10001

Other funds holding IH

Citadel Advisors's IH Position: Q1 2026 in Review

Citadel Advisors increased its iHuman (IH) stake by 21% in Q1 2026, buying an estimated $8K and bringing the position to 25,028 shares worth $42.7K. The position accounts for ﹤0.01% of the portfolio, ranked #12461.

Citadel Advisors first reported a position in IH in Q2 2021 and has held it in 12 quarters since. The position peaked at $516K in Q2 2021. 7 funds tracked by Wall St. Rank hold IH as of Q1 2026.

  • Citadel Advisors held 25,028 shares of iHuman worth $42.7K as of Q1 2026.
  • Citadel Advisors bought 4,314 iHuman shares in Q1 2026, an estimated $8K.
  • iHuman made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12461 holding.
  • Citadel Advisors first reported a position in iHuman in Q2 2021 and has held it in 12 quarters since.
  • Citadel Advisors's iHuman position peaked at $516K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held iHuman as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.